Fairmount Funds Management LLC Dbv Technologies S.A. Transaction History

Fairmount Funds Management LLC

  • $615 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$1.3 - $1.88 $368,958 - $533,570
-283,814 Reduced 4.02%
6,781,150 $9.22 Million
Q3 2022

Nov 09, 2022
BUY
$1.77 - $2.76 $3.95 Million - $6.17 Million
2,233,809 Added 46.24%
7,064,964 $12.5 Million
Q2 2022

Aug 15, 2022
BUY
$1.15 - $3.25 $5.56 Million - $15.7 Million
4,831,155 New
4,831,155 $12.3 Million

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $95.8M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email